Oversea-Chinese Banking Corp (OCBC)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.89M Sell
31,867
-5,598
-15% -$1.07M 0.15% 113
2026
Q1
$6.87M Buy
37,465
+3,099
+9% +$571K 0.19% 101
2025
Q4
$6.05M Sell
34,366
-11,837
-26% -$1.93M 0.16% 97
2025
Q3
$6.47M Buy
46,203
+223
+0.5% +$30.1K 0.16% 93
2025
Q2
$5.77M Sell
45,980
-7,300
-14% -$910K 0.16% 97
2025
Q1
$7.33M Buy
53,280
+9,014
+20% +$1.29M 0.21% 89
2024
Q4
$6.77M Buy
44,266
+28,524
+181% +$4.81M 0.19% 96
2024
Q3
$3.05M Buy
15,742
+3,145
+25% +$658K 0.08% 154
2024
Q2
$2.92M Buy
12,597
+16
+0.1% +$3.48K 0.09% 145
2024
Q1
$2.71M Buy
12,581
+811
+7% +$190K 0.08% 156
2023
Q4
$3.05M Buy
11,770
+750
+7% +$184K 0.11% 128
2023
Q3
$2.83M Buy
11,020
+1,370
+14% +$366K 0.13% 126
2023
Q2
$2.75M Hold
9,650
0.13% 124
2023
Q1
$2.68M Buy
9,650
+220
+2% +$60.9K 0.13% 111
2022
Q4
$2.61M Buy
+9,430
New +$2.66M 0.15% 107

Other funds holding BIIB

Oversea-Chinese Banking Corp (OCBC)'s BIIB Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) reduced its Biogen (BIIB) stake by 15% in Q2 2026, selling an estimated $1.07M and leaving 31,867 shares worth $6.89M. The position accounts for 0.15% of the portfolio, ranked #113.

Oversea-Chinese Banking Corp (OCBC) first reported a position in BIIB in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.33M in Q1 2025. 684 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 31,867 shares of Biogen worth $6.89M as of Q2 2026.
  • Oversea-Chinese Banking Corp (OCBC) sold 5,598 Biogen shares in Q2 2026, an estimated $1.07M.
  • Biogen made up 0.15% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #113 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Biogen in Q4 2022 and has held it in 15 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s Biogen position peaked at $7.33M in Q1 2025.
  • 684 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.